Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

Rosenbloom MH, Alkalay A, Agarwal N, Baker SL, O'Neil JP, Janabi M, Yen IV, Growdon M, Jang J, Madison C, Mormino EC, Rosen HJ, Gorno-Tempini ML, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neurology. 2011 May 24;76(21):1789-96. doi: 10.1212/WNL.0b013e31821cccad. Epub 2011 Apr 27.

2.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005. eCollection 2014.

3.

Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.

Lehmann M, Ghosh PM, Madison C, Karydas A, Coppola G, O'Neil JP, Huang Y, Miller BL, Jagust WJ, Rabinovici GD.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):266-73. doi: 10.1136/jnnp-2013-305858. Epub 2013 Aug 21.

4.

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ.

Brain. 2010 Feb;133(Pt 2):512-28. doi: 10.1093/brain/awp326. Epub 2010 Jan 15.

5.

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.

Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML.

Ann Neurol. 2008 Oct;64(4):388-401. doi: 10.1002/ana.21451.

6.

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease.

Lehmann M, Ghosh PM, Madison C, Laforce R Jr, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD.

Brain. 2013 Mar;136(Pt 3):844-58. doi: 10.1093/brain/aws327. Epub 2013 Jan 28.

7.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

8.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
9.

Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Oh H, Madison C, Baker S, Rabinovici G, Jagust W.

Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108. Epub 2016 May 13.

10.

Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.

Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.

JAMA Neurol. 2013 Jul;70(7):903-11. doi: 10.1001/jamaneurol.2013.1062.

PMID:
23712469
11.

A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.

Wang XD, Lu H, Shi Z, Cai L, Liu S, Liu S, Han T, Wang Y, Zhou Y, Wang X, Gao S, Ji Y.

PLoS One. 2015 Aug 12;10(8):e0134956. doi: 10.1371/journal.pone.0134956. eCollection 2015.

12.

Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.

Spehl TS, Hellwig S, Amtage F, Weiller C, Bormann T, Weber WA, Hüll M, Meyer PT, Frings L.

J Neuroimaging. 2015 Mar-Apr;25(2):281-8. doi: 10.1111/jon.12104. Epub 2014 Mar 5.

PMID:
24593796
13.

Amyloid-β load predicts medial temporal lobe dysfunction in Alzheimer dementia.

Frings L, Spehl TS, Weber WA, Hüll M, Meyer PT.

J Nucl Med. 2013 Nov;54(11):1909-14. doi: 10.2967/jnumed.113.120378. Epub 2013 Oct 7.

14.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

PMID:
16854944
15.

Amyloid-β and glucose metabolism in Alzheimer's disease.

Furst AJ, Lal RA.

J Alzheimers Dis. 2011;26 Suppl 3:105-16. doi: 10.3233/JAD-2011-0066.

PMID:
21971455
16.

Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia.

Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN.

Neurology. 2013 Jan 22;80(4):359-65. doi: 10.1212/WNL.0b013e31827f0889. Epub 2012 Dec 19.

PMID:
23255822
17.

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.

Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ.

Neurology. 2007 Feb 13;68(7):501-8. Epub 2006 Oct 25.

PMID:
17065593
18.

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

Raji CA, Becker JT, Tsopelas ND, Price JC, Mathis CA, Saxton JA, Lopresti BJ, Hoge JA, Ziolko SK, DeKosky ST, Klunk WE.

J Neurosci Methods. 2008 Jul 30;172(2):277-82. doi: 10.1016/j.jneumeth.2008.05.005. Epub 2008 May 16.

19.

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.

Neurology. 2006 Nov 14;67(9):1575-80. Epub 2006 Sep 13.

PMID:
16971697
20.

Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.

Jeon SY, Yi D, Byun MS, Choi HJ, Kim HJ, Lee JH, Baek H, Choe YM, Lee Y, Woo JI, Lee DY.

Neurosci Lett. 2016 Oct 6;632:104-8. doi: 10.1016/j.neulet.2016.08.045. Epub 2016 Aug 26.

PMID:
27574728

Supplemental Content

Support Center